Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2016 CHEP高血压指南：血压的测量、诊断、风险评估、预防和治疗

2016-04-07 加拿大高血压教育计划 Can J Cardiol. 2016 May;32(5):589-97.

高血压

2016年4月，加拿大高血压教育计划(CHEP)更新了血压的测量、诊断、风险评估、预防和治疗循证建议，指南新提出了4个推荐建议以及2个修订建议。

中文标题：

2016 CHEP高血压指南：血压的测量、诊断、风险评估、预防和治疗

英文标题：

Hypertension Canada’s 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension

发布机构：

加拿大高血压教育计划

发布日期：

2016-04-07

简要介绍：

2016年4月，加拿大高血压教育计划(CHEP)更新了血压的测量、诊断、风险评估、预防和治疗循证建议，指南新提出了4个推荐建议以及2个修订建议。

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 CHEP高血压指南：血压的测量、诊断、风险评估、预防和治疗)] GetToolGuiderByIdResponse(projectId=1, id=a4ba61c0012ae35e, title=2016 CHEP高血压指南：血压的测量、诊断、风险评估、预防和治疗, enTitle=Hypertension Canada’s 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension, guiderFrom=Can J Cardiol. 2016 May;32(5):589-97., authorId=null, author=, summary=2016年4月，加拿大高血压教育计划(CHEP)更新了血压的测量、诊断、风险评估、预防和治疗循证建议，指南新提出了4个推荐建议以及2个修订建议。 , cover=, journalId=null, articlesId=null, associationId=860, associationName=加拿大高血压教育计划, associationIntro=null, copyright=0, guiderPublishedTime=Thu Apr 07 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年4月，加拿大高血压教育计划(CHEP)更新了血压的测量、诊断、风险评估、预防和治疗循证建议，指南新提出了4个推荐建议以及2个修订建议。 <div><br> 拓展指南：<strong>与<font color=red>高血压</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=a398e1c0012ae2e6" title="2016版加拿大高血压教育计划高血压指南介绍" target=_blank>2016版加拿大高血压教育计划高血压指南介绍</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=3f0d11c0012ae1cf" title="2016 钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议" target=_blank>2016 钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=0b2791c0012ae06b" title="2016 CHEP高血压指南：儿童高血压血压的测量、诊断和风险评估" target=_blank>2016 CHEP高血压指南：儿童高血压血压的测量、诊断和风险评估</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=fdf1a1c0012a68bb" title="2016 NHFA指南：成人高血压的诊断和管理" target=_blank>2016 NHFA指南：成人高血压的诊断和管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e35591c0012a6447" title="2015 中国器官移植受者的高血压诊疗指南（2015版）" target=_blank>2015 中国器官移植受者的高血压诊疗指南（2015版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E9%AB%98%E8%A1%80%E5%8E%8B" target=_blank>有关高血压更多指南</a></ul></div>, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4198, appHits=174, showAppHits=0, pcHits=2986, showPcHits=1404, likes=159, shares=2, comments=7, approvalStatus=1, publishedTime=Mon Aug 01 09:51:20 CST 2016, publishedTimeString=2016-04-07, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Aug 01 09:51:20 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:30:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 CHEP高血压指南：血压的测量、诊断、风险评估、预防和治疗)])
2016 CHEP高血压指南：血压的测量、诊断、风险评估、预防和治疗
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=150965, encodeId=d4ba150965da, content=刚好需要，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73ba1969389, createdName=1e15854cm52(暂无匿称), createdTime=Tue Oct 25 00:45:47 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105187, encodeId=0b5510518e57, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:10:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99946, encodeId=8c5a99946f0, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99947, encodeId=4ab29994ee0, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99948, encodeId=51579994808, content=值得分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-10-25 1e15854cm52(暂无匿称)

    刚好需要，多谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=150965, encodeId=d4ba150965da, content=刚好需要，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73ba1969389, createdName=1e15854cm52(暂无匿称), createdTime=Tue Oct 25 00:45:47 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105187, encodeId=0b5510518e57, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:10:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99946, encodeId=8c5a99946f0, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99947, encodeId=4ab29994ee0, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99948, encodeId=51579994808, content=值得分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用，特别实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=150965, encodeId=d4ba150965da, content=刚好需要，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73ba1969389, createdName=1e15854cm52(暂无匿称), createdTime=Tue Oct 25 00:45:47 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105187, encodeId=0b5510518e57, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:10:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99946, encodeId=8c5a99946f0, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99947, encodeId=4ab29994ee0, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99948, encodeId=51579994808, content=值得分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=150965, encodeId=d4ba150965da, content=刚好需要，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73ba1969389, createdName=1e15854cm52(暂无匿称), createdTime=Tue Oct 25 00:45:47 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105187, encodeId=0b5510518e57, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:10:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99946, encodeId=8c5a99946f0, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99947, encodeId=4ab29994ee0, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99948, encodeId=51579994808, content=值得分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=150965, encodeId=d4ba150965da, content=刚好需要，多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73ba1969389, createdName=1e15854cm52(暂无匿称), createdTime=Tue Oct 25 00:45:47 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105187, encodeId=0b5510518e57, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:10:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99946, encodeId=8c5a99946f0, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99947, encodeId=4ab29994ee0, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99948, encodeId=51579994808, content=值得分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 18:02:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    值得分享

    0

相关指南

2016版加拿大高血压教育计划（CHEP）高血压指南介绍

暂未更新 · 2016-05-30

2016 钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议

中国医师协会高血压专业委员会 · 2016-04-11

2016 NHFA指南：成人高血压的诊断和管理

澳大利亚国家心脏基金会(NHFA,National Heart Foundation of Australia) · 2016-07-18

2015 中国器官移植受者的高血压诊疗指南（2015版）

中华医学会器官移植学分会 · 2016-06-14

2016 α/β受体阻滞剂在高血压治疗中应用的中国专家共识

中国医师协会高血压专业委员会 · 2016-06-30

2015 AHA/ACC/ASH 冠心病患者高血压治疗的科学声明

美国心脏病学会(ACC,American College of Cardiology) · 2015-03-30

Baidu
map
Baidu
map
Baidu
map